Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice

BACKGROUND: The randomised double-blinded placebo-controlled EXIST-1–3 studies have showed everolimus effective with adverse effects reported as acceptable in treatment of symptoms in patients with tuberous sclerosis complex (TSC), although evidence of outcomes in clinical practice remains limited....

Descripción completa

Detalles Bibliográficos
Autores principales: Cockerell, Ine, Christensen, Jakob, Hoei-Hansen, Christina E., Holst, Lotte, Grenaa Frederiksen, Mikkel, Issa-Epe, Aart Imran, Nedregaard, Bård, Solhoff, Ragnar, Heimdal, Ketil, Johannessen Landmark, Cecilie, Lund, Caroline, Nærland, Terje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693167/
https://www.ncbi.nlm.nih.gov/pubmed/38042867
http://dx.doi.org/10.1186/s13023-023-02982-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693167/
https://www.ncbi.nlm.nih.gov/pubmed/38042867
http://dx.doi.org/10.1186/s13023-023-02982-1

Ejemplares similares